Development of a Physiologically Based Pharmacokinetic Model for Hydroquinone
Authors:
- 1 June 2000
- journal article
- clinical trial
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 165 (2) , 163-174
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The Toxicology of Hydroquinone — Relevance to Occupational and Environmental ExposureCritical Reviews in Toxicology, 1999
- DIFFERENCES IN THE NEPHROTOXICITY OF HYDROQUINONE AMONG FISCHER 344 AND SPRAGUE-DAWLEY RATS AND B6C3F1 MICEJournal of Toxicology and Environmental Health, 1996
- Physiologically Based Pharmacokinetics of 2-Butoxyethanol and Its Major Metabolite, 2-Butoxyacetic Acid, in Rats and HumansToxicology and Applied Pharmacology, 1994
- Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and miceCarcinogenesis, 1992
- Development of a physiologically based pharmacokinetic model for chloroformToxicology and Applied Pharmacology, 1990
- Differential Distribution of Phenol and Catechol Sulphotransferases in Human Liver and Intestinal MucosaPharmacology, 1990
- Reductive addition of glutathione to p-benzoquinone, 2-hydroxy-p-benzoquinone, and p-benzoquinone epoxides. Effect of the hydroxy- and glutathionyl substituents on p-benzohydroquinone autoxidationChemico-Biological Interactions, 1988
- Physiologically based pharmacokinetics and the risk assessment process for methylene chlorideToxicology and Applied Pharmacology, 1987
- Metabolic fate and disposition of [14C]hydroquinone given orally to Sprague-Dawley ratsToxicology, 1984
- Toxicity Studies on Hydroquinone.Experimental Biology and Medicine, 1953